The famous leader in continuous glucose monitoring (CGM) for individuals with diabetes, DexCom, Inc., is glad to declare the verification of a benefit category and coverage for CGM by CMS (Centers for Medicare & Medicaid Services). In case to be involved in this category, the system must be termed as “therapeutic” CGM, meaning you can make treatment decisions by utilizing the device. The Dexcom G5 Mobile, today, is the mere CGM system that falls within this classification. For further information about this topic, please visit www.cms.gov/Regulations-and-Guidance/Guidance/Rulings/Downloads/CMS1682R.pdf.
0 Comments
Leave a Reply. |
Archives
September 2024
Categories
All
|